Absence d'amélioration de la prise en charge du risque cardiovasculaire dans la polyarthrite rhumatoïde débutante : résultats de la cohorte ESPOIR |
|
Actualités et nouvelles perspectives dans les rhumatismes inflammatoires chroniques SFR 2010, 28 novembre-1er décembre 2010 |
|
The effects of TNF-alpha inhibitor therapy on arterial stiffness and endothelial dysfunction in rheumatoid arthritis: a meta-analysis |
|
Epstein-Barr virus infection associated hepatic lymphoma in a patient treated with methotrexate for rheumatoid arthritis |
|
Une étude cas-témoin sur l'épaisseur intima-média et la rigidité artérielle dans la spondylarthrite ankylosante |
|
Une étude ouverte sur l'efficacité du Pamidronate intra veineux dans la discopathie dégénérative érosive |
|
Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study |
|
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial |
|
Evénements cardiovasculaires sous tocilizumab vs autres biothérapies : revue systématique avec méta-analyse en réseau |
|
Evolution de l'efficience de l'enquête bactériologique des spondylodiscites infectieuses au cours des vingt dernières années |
|
Exacerbation of interstitial lung disease during etanercept therapy: Two cases |
|
Facteurs prédictifs de réponse aux anti-TNF chez les patients souffrant d' une polyarthrite rhumatoïde ou d' une spondyloarthropathie : cohorte RCVRIC |
|
French law: what about a reasoned reimbursement of serum vitamin D assays? |
|
French survey on the crossed needs on sexual health for chronic inflammatory rheumatism patients and healthcare professionals |
|
Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients. |
|
GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate |
|
How to assess early rheumatoid arthritis in daily clinical practice |
|
Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins |
|
Impact du secukinumab sur la fonction endothéliale, la rigidité artérielle, le métabolisme glycémique et lipidique, comparativement à un traitement anti-TNF dans la spondyloarthrite axiale et le rhumatisme psoriasique |
|
Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registry |
|
Insufficiency fracture. A survey of 60 cases and review of the literature |
|
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus |
|
Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome. |
|
Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study |
|
Late-onset spondyloarthropathy mimicking reflex sympathetic dystrophy syndrome |
|
The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritis |
|
Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up. |
|
Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis |
|
Neutrophilic dermatosis of the dorsal hands during thalidomide treatment |
|
No change in the efficacy of infectious spondylodiscitis bacteriological testing over 20 years period. |
|
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial |
|
Oligo-arthritis and type IV hyperlipoproteinemia |
|
Overview of biologic treatments in the elderly |
|
Patient-perceived flares in rheumatoid arthritis: A sub-analysis of the STRASS treatment tapering strategy trial |
|
Polymyalgia rheumatica: diagnosis and treatment |
|
Polymyositis and pemphigus vulgaris in a patient: successful treatment with rituximab |
|
Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) syndrome refractory to complete serum vascular endothelial growth factor (VEGF) blockade: insights from sequential VEGF monitoring |
|
Predictive value of the usual clinical signs and laboratory tests in the diagnosis of septic arthritis |
|
Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures |
|
Prévalence de la carence en vitamine D dans la polyarthrite rhumatoïde (PR) et association avec l'activité de la maladie : données de l'étude COMEDRA |
|
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). |
|
The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study. |
|
Primary infectious spondylodiscitis in 51 patients over 75 years old: A comparative study. |
|
Psoriatic arthritis treated by anti-TNFs: a monocentric trial of 102 cases in Auvergne, France. |
|
Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de polyarthrite rhumatoïde |
|
Recommendations of the French Society for Rheumatology. TNFα antagonist therapy in rheumatoid arthritis |
|
Refractory hypocalcemia |
|
Refractory rheumatic disorder: atypical postpregnancy osteoporosis |
|
The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis |
|
Response to 'Statins accelerate the onset of collagen type II-induced arthritis in mice'. |
|
Retention rates of adalimumab, etanercept, and infliximab as first- or second-line biotherapies for spondyloarthritis patients in daily practice in Auvergne (France). |
|
Rheumatic and musculoskeletal features of Whipple disease: a report of 29 cases |
|
Rheumatic disease presenting as septic arthritis: a report of 10 cases |
|
Rheumatoid arthritis in the elderly in the era of tight control |
|
Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE. |
|
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry |
|
Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients |
|
Serious herpes zoster in rheumatoid arthritis under anti-interleukin-6 receptor antibody |
|
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis |
|
Serum procalcitonin measurement is not a useful biomarker in the detection of primary infectious spondylodiscitis. |
|
Spondyloarthropathies: an independent cardiovascular risk factor? |
|
Streptococcal septic arthritis in adults. A study of 55 cases with a literature review |
|
Le Syndrome POEMS |
|
Synovites rhumatismales : l'activité doppler varie-t-elle dans la journée? : résultats préliminaires |
|
The systemic capillary leak syndrome: a case series of 28 patients from a European registry |
|
Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases. |
|
Timing of publication of abstracts of randomized controlled trials presented in congresses: The example of the European League against Rheumatism meeting |
|
TNF alpha antagonist therapy and safety monitoring |
|
TNFα antagonist therapy does not increase the Epstein-Barr virus burden in patients with rheumatoid arthritis or ankylosing spondylitis |
|
Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients |
|
Tolérance et efficacité du rituximab chez les sujets âgés traités pour une polyarthrite rhumatoïde : les données du registre AIR |
|
Treatment of inflammatory muscle disease in adults |
|
Utility of PET/CT in the diagnosis of inflammatory rheumatic diseases: a systematic review and meta-analysis. |
|
Variations in the metabolome in response to disease activity of rheumatoid arthritis |
|
Vascular effects of nonsteroidal antiinflammatory drugs |
|
Vascular endothelial growth factor levels and rheumatic diseases of the elderly |
|
Viewpoints of dentists on the use of bisphosphonates in rheumatology patients. |
|
[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement] |
|